CA3024278A1 - Use of carbamate compound in order to preventatively treat headaches - Google Patents
Use of carbamate compound in order to preventatively treat headaches Download PDFInfo
- Publication number
- CA3024278A1 CA3024278A1 CA3024278A CA3024278A CA3024278A1 CA 3024278 A1 CA3024278 A1 CA 3024278A1 CA 3024278 A CA3024278 A CA 3024278A CA 3024278 A CA3024278 A CA 3024278A CA 3024278 A1 CA3024278 A1 CA 3024278A1
- Authority
- CA
- Canada
- Prior art keywords
- migraine
- headache
- pharmaceutical composition
- carbamate compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061374 | 2016-05-19 | ||
| KR10-2016-0061374 | 2016-05-19 | ||
| PCT/KR2017/005171 WO2017200316A1 (ko) | 2016-05-19 | 2017-05-18 | 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3024278A1 true CA3024278A1 (en) | 2017-11-23 |
Family
ID=60325338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3024278A Pending CA3024278A1 (en) | 2016-05-19 | 2017-05-18 | Use of carbamate compound in order to preventatively treat headaches |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10456376B2 (OSRAM) |
| EP (1) | EP3459541B1 (OSRAM) |
| JP (1) | JP6986521B2 (OSRAM) |
| KR (1) | KR102421006B1 (OSRAM) |
| CN (1) | CN109310670B (OSRAM) |
| CA (1) | CA3024278A1 (OSRAM) |
| ES (1) | ES2893456T3 (OSRAM) |
| WO (1) | WO2017200316A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11406620B2 (en) * | 2017-11-14 | 2022-08-09 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current |
| ES2978226T3 (es) * | 2018-09-21 | 2024-09-09 | Sk Biopharmaceuticals Co Ltd | Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático |
| CA3113052A1 (en) * | 2018-09-21 | 2020-03-26 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for prevention, alleviation, or treatment of status epilepticus |
| IL293096A (en) * | 2019-11-22 | 2022-07-01 | Sk Biopharmaceuticals Co Ltd | Oral pharmaceutical composition comprising carbamate compound and preparation method therefor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| DE2628420A1 (de) * | 1976-06-24 | 1978-01-05 | Bayer Ag | 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide |
| US4349556A (en) * | 1976-06-24 | 1982-09-14 | Bayer Aktiengesellschaft | Pesticidally active 1-acyloxy-1-phenyl-2-azolyl-ethanes |
| NZ533592A (en) * | 2001-12-21 | 2006-05-26 | Ortho Mcneil Pharm Inc | Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates |
| DE602005020667D1 (de) * | 2004-09-16 | 2010-05-27 | Janssen Pharmaceutica Nv | Verwendung von 2-phenyl-1,2-ethanediol-(di)carbamaten zur behandlung von epileptogenese |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| US8501436B2 (en) | 2009-06-22 | 2013-08-06 | Sk Biopharmaceuticals Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| CN102574344B (zh) | 2009-10-16 | 2016-03-02 | 诺华股份有限公司 | 用于运输接触透镜通过浸浴的设备及方法 |
-
2017
- 2017-05-16 KR KR1020170060706A patent/KR102421006B1/ko active Active
- 2017-05-18 JP JP2018560644A patent/JP6986521B2/ja active Active
- 2017-05-18 WO PCT/KR2017/005171 patent/WO2017200316A1/ko not_active Ceased
- 2017-05-18 ES ES17799673T patent/ES2893456T3/es active Active
- 2017-05-18 CN CN201780030914.4A patent/CN109310670B/zh active Active
- 2017-05-18 CA CA3024278A patent/CA3024278A1/en active Pending
- 2017-05-18 US US16/302,842 patent/US10456376B2/en active Active
- 2017-05-18 EP EP17799673.3A patent/EP3459541B1/en active Active
-
2019
- 2019-09-16 US US16/571,347 patent/US20200009113A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019516726A (ja) | 2019-06-20 |
| US10456376B2 (en) | 2019-10-29 |
| EP3459541B1 (en) | 2021-09-15 |
| KR20170131240A (ko) | 2017-11-29 |
| ES2893456T3 (es) | 2022-02-09 |
| JP6986521B2 (ja) | 2021-12-22 |
| CN109310670B (zh) | 2022-03-29 |
| US20190216780A1 (en) | 2019-07-18 |
| CN109310670A (zh) | 2019-02-05 |
| KR102421006B1 (ko) | 2022-07-14 |
| EP3459541A1 (en) | 2019-03-27 |
| WO2017200316A1 (ko) | 2017-11-23 |
| US20200009113A1 (en) | 2020-01-09 |
| EP3459541A4 (en) | 2020-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200009113A1 (en) | Use of carbamate compound in order to preventatively treat headaches | |
| AU2017265839B2 (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| US11571410B2 (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| IL274431B1 (en) | Use of a carbamate compound to reduce or treat developmental disorders including fragile X syndrome, Engelmann syndrome, or Rett syndrome | |
| CN113242735A (zh) | 使用氨基甲酸酯化合物预防、缓解或治疗并发的癫痫发作 | |
| EP3556363B1 (en) | Use of carbamate compound for prevention, alleviation or treatment of pruritus | |
| HK40003858A (en) | Use of carbamate compound in order to preventatively treat headaches | |
| HK40003858B (en) | Use of carbamate compound in order to preventatively treat headaches | |
| EP3854391A1 (en) | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder | |
| RU2774970C2 (ru) | Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства | |
| HK40005640A (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| HK40005640B (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| HK40015213A (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220421 |
|
| EEER | Examination request |
Effective date: 20220421 |
|
| EEER | Examination request |
Effective date: 20220421 |
|
| EEER | Examination request |
Effective date: 20220421 |
|
| EEER | Examination request |
Effective date: 20220421 |